CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 51 enrolled
Drug / intervention
Fear Reduction Intervention +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03549104
NCT03549104N/ACompleted

A Cognitive Behavioral Intervention to Reduce Fear of Hypoglycemia in Young Adults With T1DM

University of Illinois at Chicago·interventional·Posted Jun 7, 2018·Updated Jun 6, 2024

In Brief

A clinical study evaluating Fear Reduction Intervention and Attention Control for Type 1 Diabetes Mellitus. Completed, enrolled 51 participants across 1 site.

Detailed Summary

All persons with type 1 diabetes are at risk for developing hypoglycemia (low blood sugar). This is a life-threatening condition that leads to profound fear of hypoglycemia and reduced quality of life. Fear of hypoglycemia results in glucose fluctuations (from high to low glucose levels). Young adults are particularly at risk because they report high levels of fear of hypoglycemia and poor glucose control. Currently, no diabetes self-management programs specifically address how to cope with fear of hypoglycemia. The investigators propose to pilot test a fear reduction intervention (Fear Reduction Efficacy Evaluation \[FREE\]) and its effects on fear of hypoglycemia, diabetes self-management, glucose control, and glucose variability.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 7, 2018
Enrollment StartJan 14, 2019
Primary CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 8.1 years ago

Interventions

Fear Reduction Interventionbehavioral

FREE

Attention Controlbehavioral

DSMES